(Reuters) - Plethora is expected to begin a late-stage study on the
treatment in the second half of 2007.
Under the deal, Plethora will receive payments upon
achievement of regulatory and sales milestones, and royalty
payments on product sales.
Read more at Reuters.com Mergers News
treatment in the second half of 2007.
Under the deal, Plethora will receive payments upon
achievement of regulatory and sales milestones, and royalty
payments on product sales.
Read more at Reuters.com Mergers News
No comments:
Post a Comment